These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 8568233)
1. Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response. Dong RP; Kameoka J; Hegen M; Tanaka T; Xu Y; Schlossman SF; Morimoto C J Immunol; 1996 Feb; 156(4):1349-55. PubMed ID: 8568233 [TBL] [Abstract][Full Text] [Related]
2. Determination of adenosine deaminase binding domain on CD26 and its immunoregulatory effect on T cell activation. Dong RP; Tachibana K; Hegen M; Munakata Y; Cho D; Schlossman SF; Morimoto C J Immunol; 1997 Dec; 159(12):6070-6. PubMed ID: 9550406 [TBL] [Abstract][Full Text] [Related]
3. Specific binding of adenosine deaminase but not HIV-1 transactivator protein Tat to human CD26. Blanco J; Marié I; Callebaut C; Jacotot E; Krust B; Hovanessian AG Exp Cell Res; 1996 May; 225(1):102-11. PubMed ID: 8635502 [TBL] [Abstract][Full Text] [Related]
4. CD26/dipeptidyl peptidase IV does not work as an adenosine deaminase-binding protein in rat cells. Iwaki-Egawa S; Watanabe Y; Fujimoto Y Cell Immunol; 1997 Jun; 178(2):180-6. PubMed ID: 9225009 [TBL] [Abstract][Full Text] [Related]
5. Expression of ecto-adenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex. Possible role of adenosine deaminase as costimulatory molecule. Martín M; Huguet J; Centelles JJ; Franco R J Immunol; 1995 Nov; 155(10):4630-43. PubMed ID: 7594462 [TBL] [Abstract][Full Text] [Related]
6. Influence of dipeptidyl peptidase IV on enzymatic properties of adenosine deaminase. Sharoyan S; Antonyan A; Mardanyan S; Lupidi G; Cristalli G Acta Biochim Pol; 2006; 53(3):539-46. PubMed ID: 16929383 [TBL] [Abstract][Full Text] [Related]
7. The adenosine deaminase-binding region is distinct from major anti-CD26 mAb epitopes on the human dipeptidyl peptidase IV(CD26) molecule. Hühn J; Olek S; Fleischer B; von Bonin A Cell Immunol; 1999 Feb; 192(1):33-40. PubMed ID: 10066344 [TBL] [Abstract][Full Text] [Related]
8. Binding of adenosine deaminase to the lymphocyte surface via CD26. De Meester I; Vanham G; Kestens L; Vanhoof G; Bosmans E; Gigase P; Scharpé S Eur J Immunol; 1994 Mar; 24(3):566-70. PubMed ID: 7907293 [TBL] [Abstract][Full Text] [Related]
9. Adenosine deaminase binding to human CD26 is inhibited by HIV-1 envelope glycoprotein gp120 and viral particles. Valenzuela A; Blanco J; Callebaut C; Jacotot E; Lluis C; Hovanessian AG; Franco R J Immunol; 1997 Apr; 158(8):3721-9. PubMed ID: 9103436 [TBL] [Abstract][Full Text] [Related]
10. Soluble CD26 / dipeptidyl peptidase IV enhances human lymphocyte proliferation in vitro independent of dipeptidyl peptidase enzyme activity and adenosine deaminase binding. Yu DM; Slaitini L; Gysbers V; Riekhoff AG; Kähne T; Knott HM; De Meester I; Abbott CA; McCaughan GW; Gorrell MD Scand J Immunol; 2011 Feb; 73(2):102-11. PubMed ID: 21198750 [TBL] [Abstract][Full Text] [Related]
12. CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse. Pacheco R; Martinez-Navio JM; Lejeune M; Climent N; Oliva H; Gatell JM; Gallart T; Mallol J; Lluis C; Franco R Proc Natl Acad Sci U S A; 2005 Jul; 102(27):9583-8. PubMed ID: 15983379 [TBL] [Abstract][Full Text] [Related]
13. Adenosine A2B receptors behave as an alternative anchoring protein for cell surface adenosine deaminase in lymphocytes and cultured cells. Herrera C; Casadó V; Ciruela F; Schofield P; Mallol J; Lluis C; Franco R Mol Pharmacol; 2001 Jan; 59(1):127-34. PubMed ID: 11125033 [TBL] [Abstract][Full Text] [Related]
14. Regulation of adenosine receptor engagement by ecto-adenosine deaminase. Hashikawa T; Hooker SW; Maj JG; Knott-Craig CJ; Takedachi M; Murakami S; Thompson LF FASEB J; 2004 Jan; 18(1):131-3. PubMed ID: 14630704 [TBL] [Abstract][Full Text] [Related]
15. Function of dipeptidyl peptidase IV (CD26, Tp103) in transfected human T cells. Hegen M; Camerini D; Fleischer B Cell Immunol; 1993 Feb; 146(2):249-60. PubMed ID: 7909722 [TBL] [Abstract][Full Text] [Related]
16. Regulation of epithelial and lymphocyte cell adhesion by adenosine deaminase-CD26 interaction. Ginés S; Mariño M; Mallol J; Canela EI; Morimoto C; Callebaut C; Hovanessian A; Casadó V; Lluis C; Franco R Biochem J; 2002 Jan; 361(Pt 2):203-9. PubMed ID: 11772392 [TBL] [Abstract][Full Text] [Related]
17. Serum high molecular weight dipeptidyl peptidase IV (CD26) is similar to a novel antigen DPPT-L released from activated T cells. Duke-Cohan JS; Morimoto C; Rocker JA; Schlossman SF J Immunol; 1996 Mar; 156(5):1714-21. PubMed ID: 8596018 [TBL] [Abstract][Full Text] [Related]
18. Role of CD26 for CD4 memory T cell function and activation. Dong RP; Morimoto C Hum Cell; 1996 Sep; 9(3):153-62. PubMed ID: 9183643 [TBL] [Abstract][Full Text] [Related]
19. The binding site of human adenosine deaminase for CD26/Dipeptidyl peptidase IV: the Arg142Gln mutation impairs binding to cd26 but does not cause immune deficiency. Richard E; Arredondo-Vega FX; Santisteban I; Kelly SJ; Patel DD; Hershfield MS J Exp Med; 2000 Nov; 192(9):1223-36. PubMed ID: 11067872 [TBL] [Abstract][Full Text] [Related]
20. The Simpson-Golabi-Behmel syndrome causative glypican-3, binds to and inhibits the dipeptidyl peptidase activity of CD26. Davoodi J; Kelly J; Gendron NH; MacKenzie AE Proteomics; 2007 Jun; 7(13):2300-10. PubMed ID: 17549790 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]